Business Blockbuster - Helpng business to be more visible on Google

Business Daily Media


.

AIM Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S.

Multiple Institutions Give AIM a "Buy" Rating

HONG KONG SAR - Media OutReach Newswire – 5 February 2025 - AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to the U.S.

Food and Drug Administration (FDA). The vaccine has demonstrated significantly higher humoral and cellular immunity compared to internationally marketed products. If the product progresses smoothly, it will accelerate AIM Vaccine's international expansion and contribute to substantial performance growth.

In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly higher levels of specific IgG antibody titers, live-virus neutralizing antibody potency, and specific T-cell immunity compared to internationally marketed mRNA RSV control vaccines.

This announcement highlights AIM Vaccine's innovative capabilities and underscores the acceleration of its internationalization efforts, which have been recognized by multiple institutions.

Recently, FOSUN INTERNATIONAL SECURITIES initiated coverage of AIM Vaccine, assigning a "Buy" rating with a 12-month target price of HKD 11.0. The report cited the company's strong product pipeline, technological leadership, and potential for international growth as key factors. Similarly, SDICSI released a research report predicting that AIM Vaccine will launch 1-2 products annually over the next three years. If the products in development gain approval and progress smoothly in international markets, they are expected to drive new performance growth and expand market potential. SDICSI also assigned a "Buy" rating with a target price of HKD 9.5.

FOSUN INTERNATIONAL SECURITIES's analysis indicates that the Chinese vaccine market is evolving in line with global trends, where high-value products and leading companies dominate. With its differentiated advantages, AIM Vaccine is poised to secure a leading position in the domestic market while achieving scalable expansion internationally. Additionally, the company's comprehensive and iterative product portfolio is expected to enhance its market share, pricing power, and profitability, further supporting long-term growth.

The report also emphasized that AIM Vaccine, with its diversified product portfolio, technological strengths, and global expansion strategy, presents an attractive investment opportunity for investors. With a series of high-value products set to launch and profitability expected to rebound from 2025 onwards, the company is positioned for strong growth and potential valuation reassessment.

Globally, there are currently no approved antiviral drugs for RSV available for clinical use. Vaccination for active immune prophylaxis remains the most effective means to prevent severe RSV infections. No RSV vaccines have been approved for marketing in PRC. In 2023, global sales of RSV vaccines reached USD 2.46 billion, and according to industry consultants, the market size is expected to grow to approximately USD 16.7 billion by 2030.

The mRNA vaccine field is still wide open with plenty of opportunities, as there are few competitors globally. AIM Vaccine is one of the earliest companies in PRC to develop mRNA vaccine products and is among the first domestic vaccine enterprises to obtain independent patents for mRNA technology. The company has established a mature mRNA vaccine R&D system and has developed multiple mRNA candidate vaccines, including vaccines for shingles, rabies, and influenza, in addition to the mRNA RSV vaccine.
Hashtag: #AIMVaccine

The issuer is solely responsible for the content of this announcement.

News from Asia

XTransfer, VPBank and SmartPay Announce Partnership at Singapore FinTech Festival 2026

Empowering SMEs in Vietnam–China and Vietnam–ASEAN TradeSINGAPORE – Media OutReach Newswire – 19 November 2026 – XTransfer, the world's leading B2B cross-border trade payment platform, VPBank, a...

Columbia Asia Hospital Tebrau and Columbia Asia Hospital Iskandar Puteri jointly achieve Malaysia Book of Records recognition for their Mega Parenthood Workshop 2026

JOHOR BAHRU, MALAYSIA – Media OutReach Newswire – 19 November 2026 – Becoming a parent is one of life's most beautiful journeys, filled with excitement, questions and, at times, uncertainty. Recog...

Lambency Detailing becomes GTECHNIQ Accredited Detailer at both outlets and launches its new e-commerce website

Partnership brings GTECHNIQ’s accredited-only Crystal Serum Ultra to Ubi and Bukit Batok with a 10-year warranty; the new lambencydetailing.com launches the same day with online purchase and bookin...

Uthoppia House Founder Yusup Ngadimin Receives 2026 Spirit of Enterprise Start-up Award

Recognition marks a milestone in the Singapore AI company’s journey to help individuals and employers make more informed career and talent decisionsSINGAPORE– Media OutReach Newswire – 19 November...

UnionPay International Debuts Digital Trade Solution at CIIE 2026, Streamlining Cross-Border B2B Settlement for Global E-Commerce

SHANGHAI, CHINA – Media OutReach Newswire – 19 November 2026 — UnionPay International (UPI), together with Bank of China and Shanghai E&P International, today officially unveiled its Digital T...

DNA Brands Co Marks Fourth Anniversary, Building on Its Growth in Singapore’s Beauty and Wellness Industry

Celebrating four years of progress, the Singapore company looks to elevate its achievements through people, innovation and a shared passion for beauty and wellness as self-care becomes an increasin...

LittleLives, Little Lab and SEGi College Sign MOU to Explore Early Childhood Education Collaboration Across ASEAN

SUBANG JAYA, MALAYSIA - Media OutReach Newswire - 20 November 2026 – LittleLives, Little Lab and SEGi College signed a Memorandum of Understanding (MOU) on 5 November 2026 to explore collaboration...

Bosideng Marks 50 Years with ‘Warmth Code’ Exhibition in Shanghai

SHANGHAI, CHINA – Media OutReach Newswire – 20 November 2026 – Bosideng marked its 50th anniversary with 'Warmth Code: Half a Century of History', a landmark exhibition at Gate M West Bund Dream C...

Sixth Asia International Innovation and Invention Hong Kong Showcases Over 180 Innovations from the Asia-Pacific

Hong Kong Exporters’ Association’s “Hong Kong Innovation and Invention” Program exhibits at Entrepreneur Day for the fourth consecutive yearHONG KONG SAR – Media OutReach Newswire – 20 November 20...

Travel Insurance Was Built for the Few Who Claim. Ancileo’s Felt Coverage™ is for Everyone Else

There are now two kinds of travel insurance: coverage that’s contracted, and coverage that’s felt. Ancileo is the first to introduce the latter.SINGAPORE – Media OutReach Newswire – 20 November 20...

New Research Highlights What Australian Retailers Need to Deliver

New research among Australian SHEIN customers reveals how price comparisons, product quality and customer reviews are shaping purcha...

Why the secrecy around car insurance?

Every year, millions of Australians receive their car insurance renewal and promise themselves they’ll look at it properly later. Then life gets in ...

Australian workers spend almost an hour a day administering email

Research finds email filing, searching and rework consuming an estimated 58 minutes a day and potentially exposing organisations to millionsAustralian...

Customer Service Is Becoming Part of the Small Business Sales and Marketing Engine

For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating  enquiries and examine what happens after a custome...

Gift Cards as the gateway to agentic payments

Prepaid and stored value gives consumers the trust and control to try AI shopping agents By Blackhawk Network VP Head of ANZ Kieran Nolan For deca...

Why Data Accumulation Without Governance Undermines Sustainability Goals

In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...